News & Updates
Filter by Specialty:
Android fat deposition tied to increased NAFLD, fibrosis prevalence in women
An android fat deposition pattern, independent of body mass index (BMI), appears to predict higher odds of nonalcoholic fatty liver disease (NAFLD) in both men and women, but its effect on fibrosis is only seen in females, suggests a US study.
Android fat deposition tied to increased NAFLD, fibrosis prevalence in women
09 Jun 2022
Novel genetic element ties valine metabolism to heart failure in T2D
A new study presented at the recent 2022 Scientific Sessions of the American Diabetes Association (ADA 2022) has identified a novel genetic locus associated with heart failure (HF) risk among patients with type 2 diabetes (T2D). This locus appears to play a role in the metabolism of valine, a branched chain amino acid.
Novel genetic element ties valine metabolism to heart failure in T2D
09 Jun 2022
Weight loss intervention may improve COPD symptoms
In addition to cardiometabolic benefits, a lifestyle intervention aimed at weight loss in patients with chronic obstructive pulmonary disease (COPD) who are overweight or obese may reduce COPD symptoms, according to results of the INSIGHT COPD trial presented at ATS 2022.
Weight loss intervention may improve COPD symptoms
07 Jun 2022
NAFLD tied to CVD risk even in lean patients
Individuals with nonalcoholic fatty liver disease (NAFLD) – despite having a lean body or healthy BMI – are at an elevated risk for peripheral vascular disease, stroke, and cardiovascular disease (CVD), a finding that surprises gastroenterologists and researchers at DDW 2022.